Red Sea crisis impacting freight costs and transit times
Freight costs may increase by ~0.5% of revenue (~INR 30-35 crore) and transit times by 15-20 days, potentially pressuring margins and working capital.
medium · management_commentaryAjanta Pharma reported a strong Q3 FY24 with consolidated revenue of INR 1,105 crore, up 14% YoY, driven by broad-based growth across branded generics.
Financial stats pending filing verification
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Freight costs may increase by ~0.5% of revenue (~INR 30-35 crore) and transit times by 15-20 days, potentially pressuring margins and working capital.
medium · management_commentaryWhile current price erosion is stable at high single digits, any acceleration could impact US generics profitability and overall margins.
high · management_commentaryInstitutional business is lumpy and dependent on agency funding and malaria season, making it difficult to forecast.
medium · management_commentaryCardiology growth was lower than IPM due to price revision in a major product in December 2022, and competitive intensity has increased.
medium · analyst_question